GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease
- 1 September 2015
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 303, 402-411
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Striatal Neuroinflammation Promotes Parkinsonism in RatsPLOS ONE, 2009
- Two steps to functional mesenchymal stromal cells for clinical applicationTransfusion, 2007
- Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of ratsBrain Research, 2006
- Ischemic rat brain extracts induce human marrow stromal cell growth factor productionNeuropathology, 2002
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoExperimental Hematology, 2002
- Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic SystemJournal of Neurochemistry, 1998
- Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's diseaseMovement Disorders, 1998
- Glia-dependent neurotoxicity and neuroprotection in mesencephalic culturesBrain Research, 1995
- Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brainNature, 1995
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973